Agenzia Italiana del Farmaco, also known as AIFA, is the Italian Medicines Agency responsible for evaluating the quality, safety, and efficacy of medicines and medical devices in Italy. The agency operates under the supervision of the Italian Ministry of Health, and its primary goal is to protect public health by ensuring that all medicines and medical devices available in Italy are safe and effective.
AIFA is responsible for a wide range of activities, including the authorization and monitoring of clinical trials, the evaluation of new medicines and medical devices, and the supervision of post-marketing safety. The agency also plays an important role in promoting research and innovation in the field of healthcare.
One of the key features of AIFA's work is its commitment to transparency. The agency provides extensive information on its website about the medicines and medical devices it evaluates, as well as information about its decisions and the reasons behind them. This includes information on clinical trials, marketing authorizations, safety warnings, and more.
AIFA's website, agenziafarmaco.gov.it, is an excellent resource for anyone interested in learning more about the agency's work and the regulation of medicines and medical devices in Italy. The website is available in both Italian and English, and provides a wealth of information on a range of topics related to healthcare and public health.
Overall, AIFA plays a crucial role in ensuring that the medicines and medical devices available in Italy are safe and effective. Its commitment to transparency and its focus on public health make it an important resource for healthcare professionals, patients, and the general public alike.